In Reply Peiris and colleagues commented on the null effect of vitamin D supplementation on incident cancer in the ViDA study, which is based primarily on possible differential effects on disease risk between daily vs monthly doses of vitamin D supplementation. In our article, we acknowledged that monthly dosing may be less effective than daily dosing for preventing cancer, and we agree that if this finding is true, increased variability in vitamin D levels associated with monthly dosing would be a possible mechanism. For example, daily or weekly dosing of vitamin D is more effective than bolus dosing (ie, monthly) in preventing acute respiratory infections, particularly in people with vitamin D deficiency. However, the recent null findings for incident cancer reported in the VITAL study, in which a daily dose of vitamin D was administered, suggest that the frequency of dosing is not important for cancer prevention.
http://bit.ly/2GLdDjB
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου